Joshua Michael Hare, MD

Founding Director,
Interdisciplinary Stem Cell Institute
University of Miami
Miller School of Medicine

Panelist

Joshua Michael Hare, MD

Joshua Hare, MD, is a board-certified practicing cardiologist and holds the Louis Lemberg Professorship of Medicine at the University of Miami Miller School of Medicine. Hare currently serves as the founding director of the Interdisciplinary Stem Cell Institute at the University of Miami. He is widely published and has authored or co-authored over 450 articles. Hare has pioneered the use of cells as medicines for human heart disease, Alzheimer’s disease, stroke, and diseases of aging. His research has been funded by the National Institutes of Health and the Department of Defense, and he currently oversees multiple clinical trials using cell and gene therapy to treat human ischemic and non-ischemic cardiomyopathy.  Hare is an inducted member of the American Association of Physicians and the National Academy of Inventors.

Broadcast Date: 
  • Time: 

Cardiovascular diseases offer a compelling opportunity for regenerative and cellular therapies that can repair damaged tissue, promote vascularization, modulate inflammation, or restore cardiac function. However, translating research advances into meaningful therapeutics requires connecting a strong biological rationale with appropriate cell types, indications and therapeutic strategies, and patients who are most likely to benefit.

In this GEN webinar, our expert speaker will examine how therapeutically relevant research is helping shape the development of cell therapies for cardiovascular disease. His presentation will cover strategies for selecting indications, biological targets, and cell types based on disease pathophysiology and unmet clinical need. Attendees will also learn about the path from laboratory research to clinical investigation, including considerations around cell delivery and patient selection, and the clinical endpoints needed to evaluate safety and therapeutic benefit.

A live Q&A session will follow the presentation offering you a chance to pose questions to our expert panelist.

Produced with support from:

The post Advancing Cell Therapy for Cardiovascular Disease appeared first on GEN - Genetic Engineering and Biotechnology News.